EUVIMEDEUVIMED entdecken
Crossref

Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis

Yong Yang, Tianhao Xie, Peng Gao, Weijun Han, Yuhong Liu, Yanmei Wang iD

Cancer Biotherapy and Radiopharmaceuticals · 2024-12 · 39 (10) · 755-769

DOI: 10.1089/cbr.2024.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, online erschienen am 04.12.2024. Verfasst von Yong Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang City, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Glycolysis, MicroRNAs, RNA, Circular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is a leading cause of cancer-related deaths in women worldwide, posing a significant threat to female health. Therefore, it is crucial to search for new therapeutic targets and prognostic biomarkers for breast cancer patients.

Method

Bioinformatics analysis, quantitative real-time PCR (qRT-PCR), and fluorescence in situ hybridization (FISH) were employed to investigate the expression of hsa_circ_002144 in breast cancer. Transwell assay, Western blotting, and cell viability assay were utilized to assess the impact of hsa_circ_002144 on the proliferation, migration, and invasion of breast cancer cells. Additionally, a mouse model was established to validate its functionality. Flow cytometry, WB analysis, enzyme-linked immunosorbent assay (ELISA), qRT-PCR, exosomes isolation, and co-culture system were employed to elucidate the molecular mechanism underlying macrophage polarization. Result: we have discovered for the first time that hsa_circ_002144 is highly expressed in breast cancer. It affected tumor growth and metastasis and could influence macrophage polarization through the glycolytic pathway.

Conclusion

This finding provides a new direction for breast cancer treatment and prognosis assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGlycolysisMicroRNAsRNA, CircularHumansFemaleMiceAnimalsCell ProliferationTumor EscapeCell MovementCell Line, TumorPyruvate Kinase

Stichwörter der Autor:innen

PKMTAMsbreast cancerexosomesglycolysishsa_circ_002144

Substanzen

MicroRNAsRNA, CircularMIRN326 microRNA, humanPyruvate Kinase

Autor:innen und Institutionen

  • College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang City, China.
  • General Surgery, The Affiliated Hospital of Hebei University, Baoding City, China.
  • Anesthesiology department, Affiliated hospital of Qingdao university, Qingdao City, China.
  • Third Surgery, Baoji traditional Chinese Medicine Hospital in Shaanxi Province, Baoji City, China.
  • Rheumatology and Immunology Department, The Affiliated Hospital of Yan 'an University, Yan 'an City, China.
  • School of Nursing and Health, Medical College of Yan 'an University, Yan 'an City, China.

ORCID-Profile: Yanmei Wang

Zitieren

APA

Yang, Y., Xie, T., Gao, P., Han, W., Liu, Y., & Wang, Y. (2024). Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis. Cancer Biotherapy and Radiopharmaceuticals, 39(10), 755-769. https://doi.org/10.1089/cbr.2024.0009

Vancouver

Yang Y, Xie T, Gao P, Han W, Liu Y, Wang Y. Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis. Cancer Biotherapy and Radiopharmaceuticals. 2024;39(10):755-769. doi:10.1089/cbr.2024.0009

BibTeX
@article{Yang2024,
  author = {Yang, Yong and Xie, Tianhao and Gao, Peng and Han, Weijun and Liu, Yuhong and Wang, Yanmei},
  title = {Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  volume = {39},
  number = {10},
  pages = {755--769},
  doi = {10.1089/cbr.2024.0009}
}
Kostenlos starten →